These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10669066)

  • 21. Household bleach as disinfectant for use by injecting drug users.
    Watters JK; Jones TS; Shapshak P; McCoy CB; Flynn N; Gleghorn A; Vlahov D
    Lancet; 1993 Sep; 342(8873):742-3. PubMed ID: 8103844
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland.
    Vlahov D; Muñoz A; Celentano DD; Cohn S; Anthony JC; Chilcoat H; Nelson KE
    Epidemiology; 1991 Nov; 2(6):444-6. PubMed ID: 1790197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.
    Palmateer N; Hutchinson S; McAllister G; Munro A; Cameron S; Goldberg D; Taylor A
    J Viral Hepat; 2014 Jan; 21(1):25-32. PubMed ID: 24329854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study finds legalizing needles reduces HIV risk.
    AIDS Policy Law; 1995 Sep; 10(17):1, 11. PubMed ID: 11362806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for shooting gallery use among drug injectors in Puerto Rico.
    Reyes JC; Robles RR; Colón HM; Freeman DH; Sahai H; Matos TD
    P R Health Sci J; 1996 Sep; 15(3):227-31. PubMed ID: 8994289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles.
    Gostin LO; Lazzarini Z; Jones TS; Flaherty K
    JAMA; 1997 Jan; 277(1):53-62. PubMed ID: 8980211
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities.
    Thiede H; Hagan H; Campbell JV; Strathdee SA; Bailey SL; Hudson SM; Kapadia F; Garfein RS;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S39-47. PubMed ID: 17466464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.
    Heimer R; Kaplan EH; Khoshnood K; Jariwala B; Cadman EC
    Am J Med; 1993 Aug; 95(2):214-20. PubMed ID: 8356986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug injectors and the cleaning of needles and syringes.
    Hughes RA
    Eur Addict Res; 2000 Mar; 6(1):20-30. PubMed ID: 10729739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injection drug users' practices and attitudes toward intervention and potential for reducing the transmission of HIV.
    McCoy CB; Metsch LR; Page JB; McBride DC; Comerford ST
    Med Anthropol; 1997 Dec; 18(1):35-60. PubMed ID: 9458667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for shooting gallery use and cessation among intravenous drug users.
    Celentano DD; Vlahov D; Cohn S; Anthony JC; Solomon L; Nelson KE
    Am J Public Health; 1991 Oct; 81(10):1291-5. PubMed ID: 1928528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users.
    Alexander CS; Dong W; Schechter MT; O'Shaughnessy MV; Strathdee SA; Mo T; Montaner JS; Harrigan PR
    AIDS; 1999 May; 13(8):981-5. PubMed ID: 10371180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of injecting drug uses and HIV-1 infection: analysis from needle exchange program.
    Tellado I; Moran N; Vargas Vidot J; Yamamura Y
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1091-6. PubMed ID: 9449543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The validation of statements by IDUs based on the analysis of blood traces on their used syringes.
    Menoyo C; Lamikiz E; Zulaika D; Urcelai A; Zubia I; Martínez De Pancorbo M
    AIDS Care; 1998 Aug; 10(4):409-14. PubMed ID: 9828961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers--Connecticut, 1992-1993.
    Groseclose SL; Weinstein B; Jones TS; Valleroy LA; Fehrs LJ; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):82-9. PubMed ID: 7648290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential for HIV transmission through unsafe injections.
    Apetrei C; Becker J; Metzger M; Gautam R; Engle J; Wales AK; Eyong M; Enyong P; Sama M; Foley BT; Drucker E; Marx PA
    AIDS; 2006 Apr; 20(7):1074-6. PubMed ID: 16603865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of HIV-1 viral RNA in the blood in needles used for venous puncture in HIV-infected individuals.
    Rossin IR; Machado AA; Junqueira ÉM; Martinez R
    Rev Soc Bras Med Trop; 2011; 44(6):661-4. PubMed ID: 22231239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland.
    Gleghorn AA; Jones TS; Doherty MC; Celentano DD; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):97-103. PubMed ID: 7648292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between the presence of anti-Tat antibody, DNA and RNA viral load.
    Re MC; Gibellini D; Furlini G; Vignoli M; Vitone F; Bon I; La Placa M
    New Microbiol; 2001 Jul; 24(3):207-15. PubMed ID: 11497076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.